Depression in Primary care: Interpersonal Counseling vs Selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Menchetti, Marco ^a   Bortolotti, Biancamaria ^a   Rucci, Paola ^b,c   Scocco, Paolo ^d,e   Bombi, Annarosa ^a   Berardi, Domenico ^a   Affatati, V ^f   Alberini, G ^g   Baranzini, F ^g   Bellino, S ^h   Bellomo, A ⁱ   Blasi, T ^j   Bogetto, F ^h   Bortolaso, P ^g   Callegari, C ^g   Carpiniello, B ^k   Colombini, N ^l   Contu, C ^k   Croci, G ^g   De Salvia, M ⁱ   Diurni, M ^g   Elisei, S ^j   Ferretti, M ⁱ   Fiore, P ⁱ   Fusar Poli, P ^a   Iuso, S ⁱ   Lacalamita, A ^f   La Ferla, T ^j   Lia, L ^a   Luciano, C C ^a   Magnani, M ^a   Manganaro, D ^a   Martinelli, V ^m   Martino, I ^f   Montaguti, M B ^a   Nespeca, C ^a   Petito, A ⁱ   Pinna, F ^k   Piselli, M ^j   Politi, P ^m   Quartesan, R ^j   Rella, A ^j   Restaino, F ^m   Rigatelli, M ^l   Sciarini, P ^m   Simoni, E ^l   Succui, M ^a   Tedeschini, E ^l   Todarello, O ^f   Vender, S ^g   Zaccagni, L ^j   Zizza, M ^h   Lullini, G ^a   Pedrini, E ^a   D'Onghia, A ⁱ   Mazza, M ⁱ   Papagni, S ⁱ   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Department of Medicine and Public Health ^*  (Italy)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e ULSS 16   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g UNIVERSITY OF INSUBRIA   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ UNIVERSITY OF FOGGIA   (Italy)

^j UNIVERSITY OF PERUGIA   (Italy)

^k UNIVERSITY OF CAGLIARI   (Italy)

^l USL Modena   (Italy)

^m UNIVERSITY OF PAVIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; LORAZEPAM; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CONSULTATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG COST; DRUG DOSE TITRATION; HAMILTON SCALE; HUMAN; INTERPERSONAL COUNSELING; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHYSICIAN; PRIMARY MEDICAL CARE; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT BRIEF DEPRESSION; REMISSION; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ATTITUDE TO HEALTH; COUNSELING; FEMALE; HUMAN RELATION; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRIMARY HEALTH CARE; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SATISFACTION;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; COMBINED MODALITY THERAPY; COUNSELING; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PERSONAL SATISFACTION; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, BRIEF; QUESTIONNAIRES; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 78649321503     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-97     Document Type: Article

References (67)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004, 184:386-392. 10.1192/bjp.184.5.386, 15123501.
2. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002, 72(3):227-36. 10.1016/S0165-0327(01)00413-X, 12450639.
3. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995, 52:11-19.
4. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 2003, 12:22-33. 10.1002/mpr.139, 12830307.
5. Lerner D, Adler DA, Chang H, Lapitsky L, Hood MY, Perissinotto C, et al. Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv 2004, 55:1371-1378. 10.1176/appi.ps.55.12.1371, 15572564.
6. Goldberg D, Lecrubier Y. Form and frequency of mental disorders across centers. Mental Illness in General Health Care: an International Study 1995, John Wiley & Sons: Chichester, Ustun T, Sartorius N.
7. Berardi D, Leggieri G, Berti Ceroni F, et al. Depression in primary care. A nationwide epidemiological survey. Family Practice 2002, 19(4):397-400. 10.1093/fampra/19.4.397, 12110562.
8. King M, Nazareth I, Levy G, Walker C, Morris R, Weich S, et al. Prevalence of common mental disorders in general practice attendees across Europe. Br J Psychiatry 2008, 192:362-367. 10.1192/bjp.bp.107.039966, 18450661.
9. Goldberg D, Goodyear I. The origins and Course of Common Mental Disorders. 2005, Routledge; East Sussex.
10. Von Korff MR. Improving outcomes in depression. BMJ 2001, 323:948-949. 10.1136/bmj.323.7319.948, 1121496, 11679372.
11. Robinson WD, Geske JA, Prest LA, Barnacle R. Depression treatment in primary care. J Am Board Fam Pract 2005, 18:79-86. 10.3122/jabfm.18.2.79, 15798136.
12. Martín-Agueda B, López-Muñoz F, Rubio G, Guerra JA, Silva A, Alamo C. Management of depression in primary care: a survey of general practitioners in Spain. Gen Hosp Psychiatry 2005, 27(5):305-12. 10.1016/j.genhosppsych.2005.05.002, 16168789.
13. Wolf NJ, Hopko DR. Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review. Clin Psychol Rev 2008, 28:131-161. 10.1016/j.cpr.2007.04.004, 17555857.
14. Layard R. The case for psychological treatment centres. BMJ 2006, 332(7548):1030-2. 10.1136/bmj.332.7548.1030, 1450056, 16644834.
15. Williams JW, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J. Primary care physicians' approach to depressive disorders. Effects of physician specialty and practice structure. Arch Fam Med 1999, 8(1):58-67. 10.1001/archfami.8.1.58, 9932074.
16. Figueiras A, Caamano F, Gestal-Otero JJ. Influence of physician's education, drug information and medical-care settings on the quality of drugs prescribed. Eur J Clin Pharmacol 2000, 56:747-753. 10.1007/s002280000217, 11214787.
17. Dwight-Johnson M, Sherbourne CD, Liao D, Wells KB. Treatment preferences among depressed primary care patients. J Gen Intern Med 2000, 15:527-534. 10.1046/j.1525-1497.2000.08035.x, 1495573, 10940143.
18. van Schaik DJ, Klijn AF, van Hout HP, van Marwijk HW, Beekman AT, de Haan M, et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004, 26:184-189. 10.1016/j.genhosppsych.2003.12.001, 15121346.
19. American Psychiatric Association Guideline watch: practice guideline for the treatment of patients with major depressive disorder. 2005, 2, American Psychiatric Association., http://www.psychiatryonline.com/pracGuide/pracGuideTopic_7.aspx
20. National Institute for Health and Clinical Excellence Depression: the Treatment and Management of Depression in Adults. 2009, Published October 28, National Institute for Health and Clinical Excellence., http://www.nice.org.uk/CG90
21. Scott AI, Freeman CP. Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992, 304(6831):883-7. 10.1136/bmj.304.6831.883, 1882822, 1392754.
22. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995, 310:441-445. 2548821, 7873952.
23. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996, 153:1293-1300.
24. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 320:26-30. 10.1136/bmj.320.7226.26, 27250, 10617523.
25. Bedi N, Chilvers C, Churchill R, Dewey M, Duggan C, Fielding K, et al. Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry 2000, 177:312-318. 10.1192/bjp.177.4.312, 11116771.
26. Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J, et al. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008, 77:351-357. 10.1159/000151388, 18701831.
27. Williams JW, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000, 284(12):1519-26. 10.1001/jama.284.12.1519, 11000645.
28. Barrett JE, Williams JW, Oxman TE, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract 2001, 50(5):405-12.
29. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
30. Vuorilehto MS, Melartin TK, Isometsä ET. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychol Med 2009,
31. Brown C, Schulberg HC, Prigerson HG. Factors associated with symptomatic improvement and recovery from major depression in primary care patients. Gen Hosp Psychiatry 2000, 22(4):242-50. 10.1016/S0163-8343(00)00086-4, 10936631.
32. Klerman GL, Budman S, Berwick D, Weissman MM, mico-White J, Demby A, et al. Efficacy of a brief psychosocial intervention for symptoms of stress and distress among patients in primary care. Med Care 1987, 25:1078-1088. 10.1097/00005650-198711000-00006, 3695638.
33. Weissman MM. Interpersonal counselling for stress and distress in primary care: a treatment manual. 1988, http://mmw3@Columbia.edu
34. Weissman MM, Markowitz JC, Klerman GL. Comprehensive guide to interpersonal psychotherapy. 2000, New York: Basic Books.
35. Judd F, Weissman M, Davis J, Hodgins G, Piterman L. Interpersonal counselling in general practice. Aust Fam Physician 2004, 33:332-337.
36. Mossey JM, Knott KA, Higgins M, Talerico K. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci 1996, 51:M172-M178.
37. Judd FK, Piterman L, Cockram AM, McCall L, Weissman MM. A comparative study of venlafaxine with a focused education and psychotherapy program versus venlafaxine alone in the treatment of depression in general practice. Hum Psychopharmacol 2001, 16:423-428. 10.1002/hup.311, 12404563.
38. Neugebauer R, Kline J, Bleiberg K, Baxi L, Markowitz JC, Rosing M, et al. Preliminary open trial of interpersonal counseling for subsyndromal depression following miscarriage. Depress Anxiety 2007, 24:219-222. 10.1002/da.20150, 16988939.
39. Holmes A, Hodgins G, Adey S, Menzel S, Danne P, Kossmann T, et al. Trial of interpersonal counselling after major physical trauma. Aust N Z J Psychiatry 2007, 41:926-933. 10.1080/00048670701634945, 17924246.
40. Badger T, Segrin C, Dorros SM, Meek P, Lopez AM. Depression and anxiety in women with breast cancer and their partners. Nurs Res 2007, 56:44-53. 10.1097/00006199-200701000-00006, 17179873.
41. Oranta O, Luutonen S, Salokangas RK, Vahlberg T, Leino-Kilpi H. The outcomes of interpersonal counselling on depressive symptoms and distress after myocardial infarction. Nord J Psychiatry 2010, 64(2):78-86. 10.3109/08039480903402227, 19919291.
42. Frank E, Scocco P. IPT training and supervision in Italy: a model for the clinical psychiatrist across geographic and linguistic boundaries. Bulletin of the International Society for Interpersonal Psychotherapy 2003, 2(1):2-4.
43. Frank E, Cassano GB, Rucci P, Fagiolini A, Maggi L, Kraemer HC, et al. Addressing the Challenges of a Cross-National Investigation: Lessons from the Pittsburgh-Pisa Study of Treatment-Relevant Phenotypes of Unipolar Depression. Clinical Trial 2008, 5:252-261.
44. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. Interpersonal Psychotherapy of Depression. 1984, New York: Basic Books.
45. Hillerbrand ET. Cognitive differences between expert and novices: implication for group supervision. J of Counseling and Development 1989, 67:293-296.
46. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988, 45:742-747.
47. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22-33.
48. Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, et al. The Mini Intenational Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997, 12(5):224-231.
49. First MB, Gibbon M, Spitzer RL, Williams J, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). 1998, American Psychiatric Press, Washington.
50. Moller H. Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 2001, 251(Suppl 2):II13-20.
51. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17:37-49. 10.1016/0022-3956(82)90033-4, 7183759.
52. Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002, 180:461-464. 10.1192/bjp.180.5.461, 11983645.
53. De Girolamo G, Rucci P, Scocco P, Becchi A, Coppa F, D'Addario A, et al. Quality of life assessment: validation of the Italian version of the WHOQOL-Brief]. Epidemiol Psichiatr Soc 2000, 9:45-55.
54. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004, 13:299-310. 10.1023/B:QURE.0000018486.91360.00, 15085902.
55. Frank, Andrade. personal communication. 2003,
56. Horowitz, Alden, Wiggins, Pincus. Inventory of Interpersonal Problems (IIP-64). 2000, The Psychological Corporation, a Harcourt Assessment Company.
57. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983, 40:812.
58. Feeney JA, Noller P, Hanrahan M. Assessing adult attachment: Developments in the conceptualization of security and insecurity. 1994, 128-152. Attachment in adults: Theory, assessment and treatment New York: Guilford, Sperling MB, Berman WH.
59. Huxley P, Warner R. Case management, quality of life, and satisfaction with services of long-term psychiatric patients. Hosp Community Psychiatry 1992, 43:799-802.
60. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001, 178:234-241. 10.1192/bjp.178.3.234, 11230034.
61. McPartlin GM, Reynolds A, Anderson C. A comparison of once daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice. Primary Care Psychiatry 1998, 4:127-132.
62. Scott J, Sensky T. Methodological aspects of randomized controlled trials of psychotherapy in primary care. Psychol Med 2003, 33:191-196. 10.1017/S0033291702007262, 12622298.
63. Bortolotti B, Menchetti M, Bellini F, Montaguti MB, Berardi D. Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. Gen Hosp Psychiatry 2008, 30(4):293-302. 10.1016/j.genhosppsych.2008.04.001, 18585531.
64. Unützer J. Evidence-based treatments for anxiety and depression: lost in translation?. Depress Anxiety 2008, 25(9):726-9. 10.1002/da.20529, 18781657.
65. Bolton P, Bass J, Neugebauer R, Verdeli H, Clougherty KF, Wickramaratne P, et al. Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. JAMA 2003, 289:3117-3124. 10.1001/jama.289.23.3117, 12813117.
66. Wade A, Michael LO, Bang HK. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2002, 17:95-102. 10.1097/00004850-200205000-00001, 11981349.
67. Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003, 18:211-217. 10.1097/00004850-200307000-00003, 12817155.